Deep data analysis and clear visualization techniques combine to solve business problems and build strategic recommendations.

Management teams can use the insight uncovered through a micro-market segmentation exercise to inform strategic decisions on a wide range of issues, including new market entry, new product development and where best to make investments.

Case study A US-based pharmaceutical services client engaged CIL to identify opportunities for European expansion.

CIL’s advanced analytics team first extracted complex and challenging data sets involving clinical trial information from the World Health Organisation and other large-scale European health and governmental institutions. The team cleaned, processed and combined these into a single source of truth that could be used to identify the total number of active clinical trials by site and sponsor type in each European country.

When the wide-scale opportunity was understood, we undertook a detailed in-country analysis to assess the level of purchasing consolidation and distribution of sites by size and type in a specific country.

The work clearly identified countries that were most attractive to prioritize, and the site-level analysis provided a useful starting list of sales contacts (pre-quantified by scale and type of customer).

Impact:
The analysis proved instrumental in quantifying the scale of the European opportunity and informing the business’s international expansion strategy. The work clearly identified countries that were most attractive to prioritize, and the site-level analysis provided a useful starting list of sales contacts (pre-quantified by scale and type of customer).

 
Case study A US-based pharmaceutical services client engaged CIL to identify opportunities for European expansion.

CIL’s advanced analytics team first extracted complex and challenging data sets involving clinical trial information from the World Health Organisation and other large-scale European health and governmental institutions. The team cleaned, processed and combined these into a single source of truth that could be used to identify the total number of active clinical trials by site and sponsor type in each European country.

When the wide-scale opportunity was understood, we undertook a detailed in-country analysis to assess the level of purchasing consolidation and distribution of sites by size and type in a specific country.

The work clearly identified countries that were most attractive to prioritize, and the site-level analysis provided a useful starting list of sales contacts (pre-quantified by scale and type of customer).

Impact:
The analysis proved instrumental in quantifying the scale of the European opportunity and informing the business’s international expansion strategy. The work clearly identified countries that were most attractive to prioritize, and the site-level analysis provided a useful starting list of sales contacts (pre-quantified by scale and type of customer).

Get in touch If you would like to find out more about how CIL's advanced analytics practice could support you, please contact the team below.

Liam McGuinness
Liam is the Partner in charge of our advanced analytics practice, and also leads our consumer sector work.

Email

 

 

James Fothergill
James is CIL’s Advanced Analytics Manager, with oversight over all of CIL’s advanced analytics engagements

Email

 
Get in touch If you would like to find out more about how CIL's advanced analytics practice could support you, please contact the team below.

Liam McGuinness
Liam is the Partner in charge of our advanced analytics practice, and also leads our consumer sector work.

Email

 

 

James Fothergill
James is CIL’s Advanced Analytics Manager, with oversight over all of CIL’s advanced analytics engagements

Email

Sign up to our mailing list to receive our latest insights.